Thu. 21 Mar 2024, 4:19pm ET
Benzinga
Earnings, News
Asensus Surgical (AMEX:ASXC) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08) by 12.5 percent. This is unchanged from the same period last year. The company reported quarterly sales of $5.43 million which beat the analyst consensus estimate of $5.30 million by 2.47 percent. This is a 120.41 percent increase over sales of $2.46 million the same period last year.